Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function
Academic Article
Publication Date:
2017
abstract:
Background: Among endocannabinoid (EC)-related mediators, Oleoyl-ethanolamide (OEA) and Palmitoylethanolamide (PEA), two endogenous PPAR alpha agonists with lipolytic and anti-inflammatory action, respectively, are being actively investigated. Here, we assessed the potential association between plasma levels of PEA and OEA and coronary function in a cohort including normal, overweight, obese, and morbidly obese (MOB) individuals.
Iris type:
01.01 Articolo in rivista
Keywords:
Endocannabinoid system; OEA; PEA; Coronary circulation; Obesity; Adhesion molecules
List of contributors:
DI MARZO, Vincenzo
Published in: